SCHEMBL29904753

SCHEMBL29904753

COc1cccc(N2C[C@@H](C)N(C)[C@@H](C)C2)n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.50
HRH3 Q9Y5N1 1/20 0.44
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
BACE1 P56817 1/20 0.42
BACE2 Q9Y5Z0 1/20 0.42
OGA O60502 1/20 0.42
ACACB O00763 1/20 0.42
CHRM4 P08173 1/20 0.41
HTR1A P08908 2/20 0.40
HTR2A P28223 2/20 0.40
DRD3 P35462 2/20 0.40
SORD Q00796 6/20 0.40
AVPR1A P37288 1/20 0.38
HTR2C P28335 1/20 0.37
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798249 0.81 ALOX5 (0.57) ALOX5HRH3HCRTR1HCRTR2BACE1
SCHEMBL31383621 0.81 ALOX5 (0.47) ALOX5DRD3SORD
SCHEMBL31469904 0.81 ALOX5 (0.47) ALOX5DRD3SORD
SCHEMBL20343479 0.78 HCRTR1 (0.47) ALOX5HRH3HCRTR1HCRTR2BACE1
SCHEMBL2327416 0.78 ALOX5 (0.44) ALOX5HRH3HCRTR1HCRTR2BACE1
SCHEMBL7392423 0.77 ALOX5 (0.46) ALOX5HRH3HCRTR1HCRTR2BACE1
Hydrochloric Acid SCHEMBL9005370 0.76 ALOX5 (0.45) ALOX5HRH3HCRTR1HCRTR2BACE1
SCHEMBL1275290 0.76 HTR3A (0.62) ALOX5HRH3OGAHTR1AHTR2A
SCHEMBL4573088 0.76 CHRM4 (0.58) ALOX5HRH3HCRTR1HCRTR2BACE1
SCHEMBL31469888 0.75 SORD (0.37) HTR1ASORD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 WO disclosed